{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T16:50:00Z","timestamp":1782147000106,"version":"3.54.5"},"posted":{"date-parts":[[2025,11,26]]},"group-title":"In Review","reference-count":68,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,10,21]]},"abstract":"<title>Abstract<\/title>\n                <p>Background\nMyasthenia gravis (MG) is a prototypical antibody-mediated autoimmune disease with variable treatment responses with a need for biomarkers to guide therapeutic decision making. Proteomic profiling, coupled with machine learning, offers a powerful approach to identify biomarkers that may predict treatment response.\nMethods\nWe analyzed sera collected at entry (baseline) from participants in a phase 3 trial randomized trial comparing thymectomy plus prednisone versus prednisone alone, along with matched controls using liquid chromatography\u2013mass spectrometry. We derived disease-specific proteomic signatures and evaluated associations between baseline proteins and 6-month clinical outcomes using multiple machine-learning approaches with internal validation.\nResults\nBaseline serum proteomes distinguished MG from controls, with pathway enrichment implicating complement activation, immunoglobulin production, and T-cell receptor signaling. Distinct protein panels predicted 6-month clinical improvement within each treatment arm. In the thymectomy-plus-prednisone group, models captured non-linear relationships of predictive proteins in contrast with the predominant additive patterns observed in the prednisone-alone group. Predictive proteins were enriched for T-cell signaling and leukocyte trafficking functions, providing insight into treatment-specific biology.\nConclusions\nBaseline serum proteomics captures core disease characteristics of MG and predicts short-term clinical response in a treatment-specific manner. If validated in independent cohorts, these findings could enable biomarker-guided selection of thymectomy, refine risk stratification, and furnish mechanistic readouts for future MG trials and clinical care.<\/p>","DOI":"10.21203\/rs.3.rs-7915342\/v1","type":"posted-content","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T07:06:21Z","timestamp":1764140781000},"source":"Crossref","is-referenced-by-count":0,"title":["Proteomic and Machine Learning Analysis Predicts Treatment Response Signatures in Myasthenia Gravis"],"prefix":"10.21203","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3055-5213","authenticated-orcid":false,"given":"Karli Faith","family":"Gilbert","sequence":"first","affiliation":[{"name":"George Washington University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amrita K.","family":"Cheema","sequence":"additional","affiliation":[{"name":"Georgetown University Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Kaminski","sequence":"additional","affiliation":[{"name":"George Washington University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5530-2140","authenticated-orcid":false,"given":"Linda","family":"Kusner","sequence":"additional","affiliation":[{"name":"George Washington University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"issue":"12","key":"ref1","first-page":"e179742","article-title":"Myasthenia gravis: the future is here","volume":"17","author":"Kaminski HJ","unstructured":"Kaminski HJ, Sikorski P, Coronel SI, Kusner LL. Myasthenia gravis: the future is here. J Clin Invest 2024 June 17;134(12):e179742.","journal-title":"J Clin Invest 2024 June"},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/mus.27742","article-title":"The best and worst of times in therapy development for myasthenia gravis","volume":"67","author":"Benatar M","year":"2023","unstructured":"Benatar M, Cutter G, Kaminski HJ. The best and worst of times in therapy development for myasthenia gravis. Muscle Nerve. 2023;67(1):12\u20136.","journal-title":"Muscle Nerve"},{"issue":"6","key":"ref3","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1056\/NEJMoa1602489","article-title":"Randomized Trial of Thymectomy in Myasthenia Gravis","volume":"375","author":"Wolfe GI","year":"2016","unstructured":"Wolfe GI, Kaminski HJ, Aban IB, Minisman G, Kuo HC, Marx A, et al. Randomized Trial of Thymectomy in Myasthenia Gravis. N Engl J Med. 2016;375(6):511\u201322.","journal-title":"N Engl J Med"},{"issue":"6","key":"ref4","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.3390\/jcm11061597","article-title":"Current Treatment of Myasthenia Gravis","volume":"11","author":"Alhaidar MK","year":"2022","unstructured":"Alhaidar MK, Abumurad S, Soliven B, Rezania K. Current Treatment of Myasthenia Gravis. J Clin Med. 2022;11(6):1597.","journal-title":"J Clin Med"},{"issue":"2","key":"ref5","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S1474-4422(21)00463-4","article-title":"Advances and ongoing research in the treatment of autoimmune neuromuscular junction disorders","volume":"21","author":"Verschuuren JJ","year":"2022","unstructured":"Verschuuren JJ, Palace J, Murai H, Tannemaat MR, Kaminski HJ, Bril V. Advances and ongoing research in the treatment of autoimmune neuromuscular junction disorders. Lancet Neurol. 2022;21(2):189\u2013202.","journal-title":"Lancet Neurol"},{"issue":"14","key":"ref6","first-page":"3648","article-title":"The generative era of medical AI","volume":"10","author":"Fahrner LJ","unstructured":"Fahrner LJ, Chen E, Topol E, Rajpurkar P. The generative era of medical AI. Cell 2025 July 10;188(14):3648\u201360.","journal-title":"Cell 2025 July"},{"issue":"1","key":"ref7","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13059-019-1689-0","article-title":"Machine learning and complex biological data","volume":"20","author":"Xu C","year":"2019","unstructured":"Xu C, Jackson SA. Machine learning and complex biological data. Genome Biol. 2019;20(1):76.","journal-title":"Genome Biol"},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","first-page":"2465410","DOI":"10.1080\/08916934.2025.2465410","article-title":"Mitochondrial autophagy-related gene signatures associated with myasthenia gravis diagnosis and immunity","volume":"58","author":"Jin S","year":"2025","unstructured":"Jin S, Yin J, Li W, Mao N. Mitochondrial autophagy-related gene signatures associated with myasthenia gravis diagnosis and immunity. Autoimmunity. 2025;58(1):2465410.","journal-title":"Autoimmunity"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"11779322241281652","DOI":"10.1177\/11779322241281652","article-title":"Identification of Potential Key Genes for the Comorbidity of Myasthenia Gravis With Thymoma by Integrated Bioinformatics Analysis and Machine Learning","volume":"18","author":"Liu H","year":"2024","unstructured":"Liu H, Liu G, Guo R, Li S, Chang T. Identification of Potential Key Genes for the Comorbidity of Myasthenia Gravis With Thymoma by Integrated Bioinformatics Analysis and Machine Learning. Bioinforma Biol Insights. 2024;18:11779322241281652.","journal-title":"Bioinforma Biol Insights"},{"issue":"7","key":"ref10","doi-asserted-by":"crossref","first-page":"e28446","DOI":"10.1016\/j.heliyon.2024.e28446","article-title":"Screening for immune-related biomarkers associated with myasthenia gravis and dilated cardiomyopathy based on bioinformatics analysis and machine learning","volume":"10","author":"Zhou G","year":"2024","unstructured":"Zhou G, Wang S, Lin L, Lu K, Lin Z, Zhang Z, et al. Screening for immune-related biomarkers associated with myasthenia gravis and dilated cardiomyopathy based on bioinformatics analysis and machine learning. Heliyon. 2024;10(7):e28446.","journal-title":"Heliyon"},{"issue":"1","key":"ref11","first-page":"102","article-title":"Inter-alpha-trypsin inhibitor heavy chain H3 is a potential biomarker for disease activity in myasthenia gravis. Acta Neuropathol (Berl)","volume":"18","author":"Schroeter CB","year":"2024","unstructured":"Schroeter CB, Nelke C, Stascheit F, Huntemann N, Preusse C, Dobelmann V et al. Inter-alpha-trypsin inhibitor heavy chain H3 is a potential biomarker for disease activity in myasthenia gravis. Acta Neuropathol (Berl). 2024 June 18;147(1):102."},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/j.csbj.2024.04.025","article-title":"Explainable machine learning model for identifying key gut microbes and metabolites biomarkers associated with myasthenia gravis","volume":"23","author":"Chang CC","year":"2024","unstructured":"Chang CC, Liu TC, Lu CJ, Chiu HC, Lin WN. Explainable machine learning model for identifying key gut microbes and metabolites biomarkers associated with myasthenia gravis. Comput Struct Biotechnol J. 2024;23:1572\u201383.","journal-title":"Comput Struct Biotechnol J"},{"key":"ref13","doi-asserted-by":"publisher","author":"Chang CC","unstructured":"Chang CC, Liu TC, Lu CJ, Chiu HC, Lin WN. Machine learning strategy for identifying altered gut microbiomes for diagnostic screening in myasthenia gravis. Front Microbiol [Internet]. 2023 Sept 27 [cited 2025 July 15];14. Available from: https:\/\/www.frontiersin.org\/journals\/microbiology\/articles\/10.3389\/fmicb.2023.1227300\/full","DOI":"10.3389\/fmicb.2023.1227300\/full"},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"13013","DOI":"10.1038\/s41598-025-97599-8","article-title":"Serum fibrinogen is not elevated in patients with myasthenia gravis","volume":"15","author":"Bauman TA","year":"2025","unstructured":"Bauman TA, Lee SM, Juel VC, Li Y, Gilbert K, Chen J, et al. Serum fibrinogen is not elevated in patients with myasthenia gravis. Sci Rep. 2025;15(1):13013.","journal-title":"Sci Rep"},{"issue":"5","key":"ref15","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1158\/1078-0432.CCR-22-2340","article-title":"Radiotherapy Induces Innate Immune Responses in Patients Treated for Prostate Cancers","volume":"29","author":"Cheema AK","year":"2023","unstructured":"Cheema AK, Li Y, Ventimiglia M, Kowalczyk K, Hankins R, Bandi G, et al. Radiotherapy Induces Innate Immune Responses in Patients Treated for Prostate Cancers. Clin Cancer Res Off J Am Assoc Cancer Res. 2023;29(5):921\u20139.","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"issue":"10","key":"ref16","doi-asserted-by":"crossref","first-page":"4303","DOI":"10.1021\/acs.jproteome.4c00294","article-title":"Analysis and Visualization of Quantitative Proteomics Data Using FragPipe-Analyst","volume":"23","author":"Hsiao Y","year":"2024","unstructured":"Hsiao Y, Zhang H, Li GX, Deng Y, Yu F, Valipour Kahrood H, et al. Analysis and Visualization of Quantitative Proteomics Data Using FragPipe-Analyst. J Proteome Res. 2024;23(10):4303\u201315.","journal-title":"J Proteome Res"},{"issue":"2","key":"ref17","first-page":"946","article-title":"Robust hyperparameter estimation protects against hypervariable genes and improves power to detect differential expression","volume":"10","author":"Phipson B","unstructured":"Phipson B, Lee S, Majewski IJ, Alexander WS, Smyth GK. Robust hyperparameter estimation protects against hypervariable genes and improves power to detect differential expression. Ann Appl Stat. 2016 June;10(2):946\u201363.","journal-title":"Ann Appl Stat"},{"issue":"7","key":"ref18","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie ME","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47.","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"ref19","first-page":"100722","article-title":"Thirteen years of clusterProfiler","volume":"5","author":"Yu G","year":"2024","unstructured":"Yu G. Thirteen years of clusterProfiler. Innov. 2024;5(6):100722.","journal-title":"Innov"},{"issue":"5","key":"ref20","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters","volume":"16","author":"Yu G","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters. OMICS J Integr Biol. 2012;16(5):284\u20137.","journal-title":"OMICS J Integr Biol"},{"key":"ref21","first-page":"927312","article-title":"A Review of Feature Selection Methods for Machine Learning-Based Disease Risk Prediction","volume":"27","author":"Pudjihartono N","unstructured":"Pudjihartono N, Fadason T, Kempa-Liehr AW, O\u2019Sullivan JM. A Review of Feature Selection Methods for Machine Learning-Based Disease Risk Prediction. Front Bioinforma. 2022 June;27:2:927312.","journal-title":"Front Bioinforma"},{"key":"ref22","first-page":"1","article-title":"Feature Selection with the Boruta Package","volume":"16","author":"Kursa MB","unstructured":"Kursa MB, Rudnicki WR. Feature Selection with the Boruta Package. J Stat Softw 2010 Sept 16;36:1\u201313.","journal-title":"J Stat Softw 2010 Sept"},{"key":"ref23","author":"Meyer D","unstructured":"Meyer D, Dimitriadou E, Hornik K, Weingessel A, Leisch F, Chang CC et al. e1071: Misc Functions of the Department of Statistics, Probability Theory Group (Formerly: E1071), TU Wien [Internet]. 2024 [cited 2025 July 28]. Available from: https:\/\/cran.r-project.org\/web\/packages\/e1071\/index.html"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v033.i01","article-title":"Regularization Paths for Generalized Linear Models via Coordinate Descent","volume":"33","author":"Friedman J","year":"2010","unstructured":"Friedman J, Tibshirani R, Hastie T. Regularization Paths for Generalized Linear Models via Coordinate Descent. J Stat Softw. 2010;33(1):1\u201322.","journal-title":"J Stat Softw"},{"issue":"1","key":"ref25","first-page":"1","article-title":"Elastic Net Regularization Paths for All Generalized Linear Models","volume":"106","author":"Tay JK","year":"2023","unstructured":"Tay JK, Narasimhan B, Hastie T. Elastic Net Regularization Paths for All Generalized Linear Models. J Stat Softw. 2023;106(1):1\u201331.","journal-title":"J Stat Softw"},{"key":"ref26","author":"Therneau T","year":"2025","unstructured":"Therneau T, Atkinson B, rpart. Recursive Partitioning and Regression Trees [Internet]. 2025. Available from: https:\/\/CRAN.R-project.org\/package=rpart"},{"issue":"3","key":"ref27","first-page":"18","article-title":"Classification and Regression by randomForest","volume":"2","author":"Liaw A","year":"2002","unstructured":"Liaw A, Wiener M. Classification and Regression by randomForest. R News. 2002;2(3):18\u201322.","journal-title":"R News"},{"key":"ref28","author":"Olson M","year":"2017","unstructured":"Olson M, JOUSBoost. Implements Under\/Oversampling for Probability Estimation [Internet]. 2017. Available from: https:\/\/CRAN.R-project.org\/package=JOUSBoost"},{"key":"ref29","doi-asserted-by":"publisher","author":"Chen T","unstructured":"Chen T, Guestrin C, XGBoost:. A Scalable Tree Boosting System. In: Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining [Internet]. New York, NY, USA: Association for Computing Machinery; 2016 [cited 2025 Sept 16]. pp. 785\u201394. (KDD \u201916). Available from: https:\/\/dl.acm.org\/doi\/10.1145\/2939672.2939785","DOI":"10.1145\/2939672.2939785"},{"issue":"8","key":"ref30","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1038\/s41592-025-02748-6","article-title":"GeneAgent: self-verification language agent for gene-set analysis using domain databases","volume":"22","author":"Wang Z","year":"2025","unstructured":"Wang Z, Jin Q, Wei CH, Tian S, Lai PT, Zhu Q, et al. GeneAgent: self-verification language agent for gene-set analysis using domain databases. Nat Methods. 2025;22(8):1677\u201385.","journal-title":"Nat Methods"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/j.1749-6632.1998.tb11015.x","article-title":"Reliability testing of the quantitative myasthenia gravis score","volume":"841","author":"Barohn RJ","year":"1998","unstructured":"Barohn RJ, McIntire D, Herbelin L, Wolfe GI, Nations S, Bryan WW. Reliability testing of the quantitative myasthenia gravis score. Ann N Y Acad Sci. 1998;841:769\u201372.","journal-title":"Ann N Y Acad Sci"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"105231","DOI":"10.1016\/j.ebiom.2024.105231","article-title":"Identification of disease phenotypes in acetylcholine receptor-antibody myasthenia gravis using proteomics-based consensus clustering","volume":"105","author":"Nelke C","unstructured":"Nelke C, Schroeter CB, Barman S, Stascheit F, Masanneck L, Theissen L, et al. Identification of disease phenotypes in acetylcholine receptor-antibody myasthenia gravis using proteomics-based consensus clustering. EBioMedicine. 2024 July;105:105231.","journal-title":"EBioMedicine"},{"issue":"2","key":"ref33","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1124\/pr.119.018101","article-title":"Transitioning from Basic toward Systems Pharmacodynamic Models: Lessons from Corticosteroids","volume":"72","author":"Ayyar VS","year":"2020","unstructured":"Ayyar VS, Jusko WJ. Transitioning from Basic toward Systems Pharmacodynamic Models: Lessons from Corticosteroids. Pharmacol Rev. 2020;72(2):414\u201338.","journal-title":"Pharmacol Rev"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"721","DOI":"10.3389\/fimmu.2018.00721","article-title":"Extracellular Vesicles: Packages Sent With Complement","volume":"9","author":"Karasu E","year":"2018","unstructured":"Karasu E, Eisenhardt SU, Harant J, Huber-Lang M. Extracellular Vesicles: Packages Sent With Complement. Front Immunol. 2018;9:721.","journal-title":"Front Immunol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"917","DOI":"10.3389\/fimmu.2020.00917","article-title":"Complement Inhibitor Therapy for Myasthenia Gravis","volume":"11","author":"Albazli K","year":"2020","unstructured":"Albazli K, Kaminski HJ, Howard JF. Complement Inhibitor Therapy for Myasthenia Gravis. Front Immunol. 2020;11:917.","journal-title":"Front Immunol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/bs.irn.2025.04.031","article-title":"Neuromuscular junction and the complement system","volume":"182","author":"Jacob S","year":"2025","unstructured":"Jacob S, Howard JF. Neuromuscular junction and the complement system. Int Rev Neurobiol. 2025;182:21\u201342.","journal-title":"Int Rev Neurobiol"},{"issue":"10","key":"ref37","doi-asserted-by":"crossref","first-page":"e0205464","DOI":"10.1371\/journal.pone.0205464","article-title":"MicroRNA and mRNA expression associated with ectopic germinal centers in thymus of myasthenia gravis","volume":"13","author":"Sengupta M","year":"2018","unstructured":"Sengupta M, Wang BD, Lee NH, Marx A, Kusner LL, Kaminski HJ. MicroRNA and mRNA expression associated with ectopic germinal centers in thymus of myasthenia gravis. PLoS ONE. 2018;13(10):e0205464.","journal-title":"PLoS ONE"},{"issue":"1","key":"ref38","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ajpath.2020.09.007","article-title":"Novel Functions of the Septin Cytoskeleton: Shaping Up Tissue Inflammation and Fibrosis","volume":"191","author":"Ivanov AI","year":"2021","unstructured":"Ivanov AI, Le HT, Naydenov NG, Rieder F. Novel Functions of the Septin Cytoskeleton: Shaping Up Tissue Inflammation and Fibrosis. Am J Pathol. 2021;191(1):40\u201351.","journal-title":"Am J Pathol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1569285","DOI":"10.3389\/fphys.2025.1569285","article-title":"Beyond structural domains: the emerging roles of PDLIM2 in cellular signaling and cancer progression","volume":"16","author":"Shi Y","year":"2025","unstructured":"Shi Y, Fan T, Yang Y, Liu J, Ouyang J, Dai J. Beyond structural domains: the emerging roles of PDLIM2 in cellular signaling and cancer progression. Front Physiol. 2025;16:1569285.","journal-title":"Front Physiol"},{"issue":"10","key":"ref40","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.tibs.2019.05.004","article-title":"Transgelin-2: Biochemical and Clinical Implications in Cancer and Asthma","volume":"44","author":"Yin LM","year":"2019","unstructured":"Yin LM, Ulloa L, Yang YQ. Transgelin-2: Biochemical and Clinical Implications in Cancer and Asthma. Trends Biochem Sci. 2019;44(10):885\u201396.","journal-title":"Trends Biochem Sci"},{"issue":"1","key":"ref41","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1038\/s41598-019-39882-z","article-title":"Src in endosomal membranes promotes exosome secretion and tumor progression","volume":"9","author":"Hikita T","year":"2019","unstructured":"Hikita T, Kuwahara A, Watanabe R, Miyata M, Oneyama C. Src in endosomal membranes promotes exosome secretion and tumor progression. Sci Rep. 2019;9(1):3265.","journal-title":"Sci Rep"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1206539","DOI":"10.3389\/fcell.2023.1206539","article-title":"Regulation, targets and functions of CSK","volume":"11","author":"Zhu S","year":"2023","unstructured":"Zhu S, Wang H, Ranjan K, Zhang D. Regulation, targets and functions of CSK. Front Cell Dev Biol. 2023;11:1206539.","journal-title":"Front Cell Dev Biol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"697204","DOI":"10.3389\/fendo.2021.697204","article-title":"Roles of Skeletal Muscle-Derived Exosomes in Organ Metabolic and Immunological Communication","volume":"12","author":"Aoi W","year":"2021","unstructured":"Aoi W, Tanimura Y. Roles of Skeletal Muscle-Derived Exosomes in Organ Metabolic and Immunological Communication. Front Endocrinol. 2021;12:697204.","journal-title":"Front Endocrinol"},{"issue":"8","key":"ref44","doi-asserted-by":"crossref","first-page":"e1010357","DOI":"10.1371\/journal.pcbi.1010357","article-title":"Ten quick tips for biomarker discovery and validation analyses using machine learning","volume":"18","author":"Diaz-Uriarte R","year":"2022","unstructured":"Diaz-Uriarte R, G\u00f3mez de Lope E, Giugno R, Fr\u00f6hlich H, Nazarov PV, Nepomuceno-Chamorro IA, et al. Ten quick tips for biomarker discovery and validation analyses using machine learning. PLoS Comput Biol. 2022;18(8):e1010357.","journal-title":"PLoS Comput Biol"},{"key":"ref45","author":"Zhang X","unstructured":"Zhang X, Jonassen I, Goks\u00f8yr A. Machine Learning Approaches for Biomarker Discovery Using Gene Expression Data. In: Helder I. N, editor. Bioinformatics [Internet]. Brisbane (AU): Exon Publications; 2021 [cited 2025 July 24]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK569564\/"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1580219","DOI":"10.3389\/fimmu.2025.1580219","article-title":"Identification of potential prognostic biomarkers of thymoma with myasthenia gravis based on serum proteomics","volume":"16","author":"Lin X","year":"2025","unstructured":"Lin X, Qi G, Liu P. Identification of potential prognostic biomarkers of thymoma with myasthenia gravis based on serum proteomics. Front Immunol. 2025;16:1580219.","journal-title":"Front Immunol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.3389\/fimmu.2019.01068","article-title":"L-selectin: A Major Regulator of Leukocyte Adhesion, Migration and Signaling","volume":"10","author":"Ivetic A","year":"2019","unstructured":"Ivetic A, Hoskins Green HL, Hart SJ. L-selectin: A Major Regulator of Leukocyte Adhesion, Migration and Signaling. Front Immunol. 2019;10:1068.","journal-title":"Front Immunol"},{"issue":"3","key":"ref48","doi-asserted-by":"crossref","first-page":"jcs250340","DOI":"10.1242\/jcs.250340","article-title":"L-selectin regulates human neutrophil transendothelial migration","volume":"134","author":"Rahman I","year":"2021","unstructured":"Rahman I, Collado S\u00e1nchez A, Davies J, Rzeniewicz K, Abukscem S, Joachim J, et al. L-selectin regulates human neutrophil transendothelial migration. J Cell Sci. 2021;134(3):jcs250340.","journal-title":"J Cell Sci"},{"issue":"8","key":"ref49","doi-asserted-by":"crossref","first-page":"110564","DOI":"10.1016\/j.isci.2024.110564","article-title":"Serum protein biomarker profile distinguishes acetylcholine receptor antibody seropositive myasthenia gravis patients from healthy controls","volume":"27","author":"Bhandage AK","year":"2024","unstructured":"Bhandage AK, Kenina V, Huang YF, Roddate M, Kauke G, Grosmane A, et al. Serum protein biomarker profile distinguishes acetylcholine receptor antibody seropositive myasthenia gravis patients from healthy controls. iScience. 2024;27(8):110564.","journal-title":"iScience"},{"key":"ref50","doi-asserted-by":"publisher","author":"Bhandage AK","unstructured":"Bhandage AK, Punga AR. Inflammatory imbalance and activation deficits in T cells of myasthenia gravis patients revealed by proteomic profiling. Front Immunol [Internet]. 2025 Aug 4 [cited 2025 Aug 11];16. Available from: https:\/\/www.frontiersin.org\/journals\/immunology\/articles\/10.3389\/fimmu.2025.1648020\/full","DOI":"10.3389\/fimmu.2025.1648020\/full"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"39716","DOI":"10.1038\/srep39716","article-title":"Profile of upregulated inflammatory proteins in sera of Myasthenia Gravis patients","volume":"7","author":"Molin CJ","year":"2017","unstructured":"Molin CJ, Westerberg E, Punga AR. Profile of upregulated inflammatory proteins in sera of Myasthenia Gravis patients. Sci Rep. 2017;7:39716.","journal-title":"Sci Rep"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.imlet.2023.07.001","article-title":"A skewed ratio of free light chains is more common in patients with late-onset than early-onset myasthenia gravis","volume":"260","author":"Myllynen C","year":"2023","unstructured":"Myllynen C, Sarkkinen J, Atula S, Tienari P, Kek\u00e4l\u00e4inen E, Laakso SM. A skewed ratio of free light chains is more common in patients with late-onset than early-onset myasthenia gravis. Immunol Lett. 2023;260:81\u20138.","journal-title":"Immunol Lett"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1382320","DOI":"10.3389\/fimmu.2024.1382320","article-title":"B-cell immune dysregulation with low soluble CD22 levels in refractory seronegative myasthenia gravis","volume":"15","author":"Okuzono Y","year":"2024","unstructured":"Okuzono Y, Miyakawa S, Itou T, Sagara M, Iwata M, Ishizuchi K, et al. B-cell immune dysregulation with low soluble CD22 levels in refractory seronegative myasthenia gravis. Front Immunol. 2024;15:1382320.","journal-title":"Front Immunol"},{"issue":"Suppl 1","key":"ref54","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s00393-021-01142-9","article-title":"Serum S100A12 levels in children with childhood-onset systemic lupus erythematosus, systemic juvenile arthritis, and systemic undefined recurrent fevers","volume":"82","author":"Bobek D","year":"2023","unstructured":"Bobek D, Sestan M, Mijacika L, Kovacic N, Lukic IK, Grcevic D, et al. Serum S100A12 levels in children with childhood-onset systemic lupus erythematosus, systemic juvenile arthritis, and systemic undefined recurrent fevers. Z Rheumatol. 2023;82(Suppl 1):74\u20139.","journal-title":"Z Rheumatol"},{"issue":"1","key":"ref55","doi-asserted-by":"crossref","first-page":"24","DOI":"10.2174\/156652413804486214","article-title":"Functions of S100 Proteins","volume":"13","author":"Donato R","year":"2013","unstructured":"Donato R, Cannon BR, Sorci G, Riuzzi F, Hsu K, Weber DJ, et al. Functions of S100 Proteins. Curr Mol Med. 2013;13(1):24\u201357.","journal-title":"Curr Mol Med"},{"issue":"1","key":"ref56","first-page":"235","article-title":"T cells in health and disease","volume":"19","author":"Sun L","unstructured":"Sun L, Su Y, Jiao A, Wang X, Zhang B. T cells in health and disease. Signal Transduct Target Ther. 2023 June;19(1):235.","journal-title":"Signal Transduct Target Ther"},{"key":"ref57","author":"Rodriguez OL","unstructured":"Rodriguez OL, Safonova Y, Silver CA, Shields K, Gibson WS, Kos JT et al. Genetic variation in the immunoglobulin heavy chain locus shapes the human antibody repertoire. Nat Commun. 2023 July 21;14(1):4419."},{"issue":"11","key":"ref58","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.molmed.2023.08.002","article-title":"The emerging Janus face of SVEP1 in development and disease","volume":"29","author":"Elenbaas JS","year":"2023","unstructured":"Elenbaas JS, Jung IH, Coler-Reilly A, Lee PC, Alisio A, Stitziel NO. The emerging Janus face of SVEP1 in development and disease. Trends Mol Med. 2023;29(11):939\u201350.","journal-title":"Trends Mol Med"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"110657","DOI":"10.1016\/j.compbiomed.2025.110657","article-title":"Developing a Panel of Shared Susceptibility Genes as Diagnostic Biomarkers for chronic obstructive pulmonary disease and Heart Failure","volume":"196","author":"Li H","unstructured":"Li H, Huang C, Su R, Wang M, Ma Y, Wang Y, et al. Developing a Panel of Shared Susceptibility Genes as Diagnostic Biomarkers for chronic obstructive pulmonary disease and Heart Failure. Comput Biol Med. 2025 Sept;196:110657.","journal-title":"Comput Biol Med"},{"issue":"1","key":"ref60","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11897-025-00698-w","article-title":"Clinical Insights from Proteomics in Heart Failure","volume":"22","author":"Lotfinaghsh A","year":"2025","unstructured":"Lotfinaghsh A, Imam A, Pompian A, Stitziel NO, Javaheri A. Clinical Insights from Proteomics in Heart Failure. Curr Heart Fail Rep. 2025;22(1):12.","journal-title":"Curr Heart Fail Rep"},{"issue":"3","key":"ref61","doi-asserted-by":"crossref","first-page":"e161","DOI":"10.1002\/mco2.161","article-title":"Heat shock proteins: Biological functions, pathological roles, and therapeutic opportunities","volume":"3","author":"Hu C","year":"2022","unstructured":"Hu C, Yang J, Qi Z, Wu H, Wang B, Zou F, et al. Heat shock proteins: Biological functions, pathological roles, and therapeutic opportunities. MedComm. 2022;3(3):e161.","journal-title":"MedComm"},{"issue":"1","key":"ref62","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.gene.2015.06.018","article-title":"Regulation and function of the human HSP90AA1 gene","volume":"570","author":"Zuehlke AD","year":"2015","unstructured":"Zuehlke AD, Beebe K, Neckers L, Prince T. Regulation and function of the human HSP90AA1 gene. Gene. 2015;570(1):8\u201316.","journal-title":"Gene"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3389\/fneur.2017.00230","article-title":"The Role of Osteopontin and Its Gene on Glucocorticoid Response in Myasthenia Gravis","volume":"8","author":"Xie Y","year":"2017","unstructured":"Xie Y, Li HF, Sun L, Kusner LL, Wang S, Meng Y, et al. The Role of Osteopontin and Its Gene on Glucocorticoid Response in Myasthenia Gravis. Front Neurol. 2017;8:230.","journal-title":"Front Neurol"},{"issue":"1","key":"ref64","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1586\/1744666X.4.1.43","article-title":"Effect of complement and its regulation on myasthenia gravis pathogenesis","volume":"4","author":"Kusner LL","year":"2008","unstructured":"Kusner LL, Kaminski HJ, Soltys J. Effect of complement and its regulation on myasthenia gravis pathogenesis. Expert Rev Clin Immunol. 2008;4(1):43\u201352.","journal-title":"Expert Rev Clin Immunol"},{"issue":"4","key":"ref65","first-page":"1127","article-title":"Distinct CD55 Isoform Synthesis and Inhibition of Complement-Dependent Cytolysis by Hepatitis C Virus","volume":"197","author":"Kwon YC","year":"2016","unstructured":"Kwon YC, Kim H, Meyer K, Di Bisceglie AM, Ray R. Distinct CD55 Isoform Synthesis and Inhibition of Complement-Dependent Cytolysis by Hepatitis C Virus. J Immunol Baltim Md 1950. 2016;197(4):1127\u201336.","journal-title":"J Immunol Baltim Md 1950"},{"issue":"1","key":"ref66","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/s41598-020-57592-9","article-title":"The Asthma-associated PER1-like domain-containing protein 1 (PERLD1) Haplotype Influences Soluble Glycosylphosphatidylinositol Anchor Protein (sGPI-AP) Levels in Serum and Immune Cell Proliferation","volume":"10","author":"Sio YY","year":"2020","unstructured":"Sio YY, Anantharaman R, Lee SQE, Matta SA, Ng YT, Chew FT. The Asthma-associated PER1-like domain-containing protein 1 (PERLD1) Haplotype Influences Soluble Glycosylphosphatidylinositol Anchor Protein (sGPI-AP) Levels in Serum and Immune Cell Proliferation. Sci Rep. 2020;10(1):715.","journal-title":"Sci Rep"},{"issue":"6","key":"ref67","doi-asserted-by":"crossref","first-page":"e0197435","DOI":"10.1371\/journal.pone.0197435","article-title":"Histopathology of thymectomy specimens from the MGTX-trial: Entropy analysis as strategy to quantify spatial heterogeneity of lymphoid follicle and fat distribution","volume":"13","author":"Weis CA","year":"2018","unstructured":"Weis CA, Aban IB, Cutter G, Kaminski HJ, Scharff C, Grie\u00dfmann BW, et al. Histopathology of thymectomy specimens from the MGTX-trial: Entropy analysis as strategy to quantify spatial heterogeneity of lymphoid follicle and fat distribution. PLoS ONE. 2018;13(6):e0197435.","journal-title":"PLoS ONE"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"886625","DOI":"10.3389\/fneur.2022.886625","article-title":"Corticosteroid Treatment-Resistance in Myasthenia Gravis","volume":"13","author":"Kaminski HJ","year":"2022","unstructured":"Kaminski HJ, Denk J. Corticosteroid Treatment-Resistance in Myasthenia Gravis. Front Neurol. 2022;13:886625.","journal-title":"Front Neurol"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-7915342\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-7915342\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T16:17:45Z","timestamp":1782145065000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-7915342\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":68,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-7915342\/v1","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1186\/s12967-026-08458-7","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2025,11,26]]},"subtype":"preprint"}}